Tilray (TLRY) Valuation Check After Schedule III Cannabis Rescheduling Rally and Margin Upside Hopes

Tilray Brands (TLRY) just rode a wave of optimism after reports that President Trump plans to reclassify marijuana to Schedule III, a potential game changer for taxes, banking access, and long term profitability.

See our latest analysis for Tilray Brands.

Even after today’s 44.1% one day share price return to $12.15 and a 68.8% seven day share price return, Tilray’s year to date share price return remains negative, while the three year total shareholder return is still deeply underwater. The recent rally looks more like momentum rebuilding around rescheduling hopes, the reverse split, and new product launches than the end of a volatile chapter.

If Tilray’s rebound has you rethinking the cannabis and beverage space, this could be a good moment to explore fast growing stocks with high insider ownership for other fast moving ideas with skin in the game.

With Tilray still trading at a discount to analyst targets but carrying heavy losses, the key question now is whether this latest surge leaves shares undervalued or if the market is already pricing in the next leg of growth.

Most Popular Narrative: 24.8% Undervalued

Tilray Brands last closed at $12.15, while the most followed narrative pegs fair value far higher, creating a sharp gap between sentiment and price.

Operational scale from strategic acquisitions (craft beer/spirits) and production footprint consolidation (now 90% in house) is enabling continued cost optimization, SKU rationalization, and manufacturing efficiency, which is expected to translate into stronger gross/net margins and improved EBITDA in upcoming periods.

Read the complete narrative.

Curious how modest revenue growth assumptions could translate into sizeable future earnings and a richer profit multiple than today? The narrative focuses on transformed margins, disciplined expansion, and a specific path for earnings to align with that higher fair value. Want to see the detailed roadmap behind that potential shift in profitability and valuation?

Result: Fair Value of $16.17 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, persistent U.S. regulatory delays and continued Canadian price pressure could blunt Tilray’s path to profitability and undermine today’s renewed optimism.

Find out about the key risks to this Tilray Brands narrative.

Another Angle on Value

While the narrative suggests Tilray is 24.8 percent undervalued, our DCF model paints a cooler picture, putting fair value closer to 10.97 dollars per share, below the current 12.15 dollars. If cash flows cannot catch up with the story, how long can this gap last?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Tilray Brands for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 911 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

Build Your Own Tilray Brands Narrative

If you see the story differently or want to test your own assumptions against the numbers, you can build a personalized view in just a few minutes using Do it your way.

A great starting point for your Tilray Brands research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.

Ready for more investment ideas?

Do not stop with one opportunity. Use the Simply Wall St Screener to quickly uncover fresh stocks, hidden value, and new themes that could reshape your portfolio.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com